Fuji Pharma Co., Ltd. (4554.T)
JPY 1536.0
(0.26%)
JPY 1536.0
(0.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.65 Billion JPY | 17.4% |
| 2022 | 10.77 Billion JPY | -5.45% |
| 2021 | 11.39 Billion JPY | -2.81% |
| 2020 | 11.72 Billion JPY | 0.95% |
| 2019 | 11.61 Billion JPY | 0.55% |
| 2018 | 11.55 Billion JPY | 11.14% |
| 2017 | 10.39 Billion JPY | 4.35% |
| 2016 | 9.96 Billion JPY | 2.56% |
| 2015 | 9.71 Billion JPY | 5.56% |
| 2014 | 9.2 Billion JPY | 19.91% |
| 2013 | 7.67 Billion JPY | 31.8% |
| 2012 | 5.82 Billion JPY | -2.31% |
| 2011 | 5.96 Billion JPY | 15.92% |
| 2010 | 5.14 Billion JPY | 10.01% |
| 2009 | 4.67 Billion JPY | 23.66% |
| 2008 | 3.77 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.01 Billion JPY | -18.39% |
| 2024 Q1 | 3.69 Billion JPY | 4.62% |
| 2024 Q3 | 3.5 Billion JPY | 16.4% |
| 2023 Q3 | 3.32 Billion JPY | 12.45% |
| 2023 Q4 | 3.52 Billion JPY | 6.17% |
| 2023 FY | 12.65 Billion JPY | 17.4% |
| 2023 Q1 | 2.84 Billion JPY | -12.2% |
| 2023 Q2 | 2.95 Billion JPY | 3.97% |
| 2022 Q2 | 2.52 Billion JPY | 3.24% |
| 2022 Q1 | 2.44 Billion JPY | -36.93% |
| 2022 FY | 10.77 Billion JPY | -5.45% |
| 2022 Q4 | 3.23 Billion JPY | 25.7% |
| 2022 Q3 | 2.57 Billion JPY | 2.18% |
| 2021 Q2 | 2.64 Billion JPY | 13.06% |
| 2021 FY | 11.39 Billion JPY | -2.81% |
| 2021 Q1 | 2.33 Billion JPY | -21.48% |
| 2021 Q3 | 2.54 Billion JPY | -3.48% |
| 2021 Q4 | 3.87 Billion JPY | 51.9% |
| 2020 Q1 | 3.01 Billion JPY | -11.59% |
| 2020 FY | 11.72 Billion JPY | 0.95% |
| 2020 Q2 | 2.9 Billion JPY | -3.72% |
| 2020 Q3 | 2.83 Billion JPY | -2.14% |
| 2020 Q4 | 2.97 Billion JPY | 4.79% |
| 2019 Q4 | 3.4 Billion JPY | 23.66% |
| 2019 FY | 11.61 Billion JPY | 0.55% |
| 2019 Q1 | 2.89 Billion JPY | -9.93% |
| 2019 Q2 | 2.56 Billion JPY | -11.54% |
| 2019 Q3 | 2.75 Billion JPY | 7.66% |
| 2018 Q2 | 2.78 Billion JPY | -2.31% |
| 2018 Q1 | 2.85 Billion JPY | -8.82% |
| 2018 Q3 | 2.69 Billion JPY | -3.26% |
| 2018 Q4 | 3.21 Billion JPY | 19.09% |
| 2018 FY | 11.55 Billion JPY | 11.14% |
| 2017 FY | 10.39 Billion JPY | 4.35% |
| 2017 Q3 | 2.4 Billion JPY | -1.43% |
| 2017 Q2 | 2.44 Billion JPY | 1.03% |
| 2017 Q1 | 2.41 Billion JPY | -15.16% |
| 2017 Q4 | 3.13 Billion JPY | 30.08% |
| 2016 Q4 | 2.84 Billion JPY | 30.45% |
| 2016 FY | 9.96 Billion JPY | 2.56% |
| 2016 Q1 | 2.66 Billion JPY | 10.23% |
| 2016 Q2 | 2.27 Billion JPY | -14.69% |
| 2016 Q3 | 2.18 Billion JPY | -3.79% |
| 2015 Q3 | 2.32 Billion JPY | -9.59% |
| 2015 FY | 9.71 Billion JPY | 5.56% |
| 2015 Q1 | 2.41 Billion JPY | -6.61% |
| 2015 Q2 | 2.56 Billion JPY | 6.25% |
| 2015 Q4 | 2.41 Billion JPY | 4.05% |
| 2014 FY | 9.2 Billion JPY | 19.91% |
| 2014 Q4 | 2.58 Billion JPY | 21.58% |
| 2014 Q3 | 2.12 Billion JPY | -8.75% |
| 2014 Q2 | 2.33 Billion JPY | 7.97% |
| 2014 Q1 | 2.15 Billion JPY | 2.91% |
| 2013 Q4 | 2.09 Billion JPY | 7.98% |
| 2013 Q3 | 1.94 Billion JPY | 8.37% |
| 2013 FY | 7.67 Billion JPY | 31.8% |
| 2013 Q2 | 1.79 Billion JPY | -2.61% |
| 2013 Q1 | 1.84 Billion JPY | 101.66% |
| 2012 Q1 | 1.69 Billion JPY | 61.77% |
| 2012 Q4 | 912.9 Million JPY | -43.54% |
| 2012 Q3 | 1.61 Billion JPY | 1.16% |
| 2012 FY | 5.82 Billion JPY | -2.31% |
| 2012 Q2 | 1.59 Billion JPY | -5.71% |
| 2011 Q4 | 1.04 Billion JPY | -34.34% |
| 2011 Q1 | 1.58 Billion JPY | 77.48% |
| 2011 FY | 5.96 Billion JPY | 15.92% |
| 2011 Q3 | 1.59 Billion JPY | -7.96% |
| 2011 Q2 | 1.73 Billion JPY | 9.53% |
| 2010 Q4 | 891.95 Million JPY | -37.16% |
| 2010 Q2 | 1.4 Billion JPY | -1.13% |
| 2010 Q3 | 1.41 Billion JPY | 0.84% |
| 2010 Q1 | 1.42 Billion JPY | 69.51% |
| 2010 FY | 5.14 Billion JPY | 10.01% |
| 2009 Q1 | 1.19 Billion JPY | 0.0% |
| 2009 Q2 | 1.24 Billion JPY | 4.0% |
| 2009 Q3 | 1.38 Billion JPY | 11.44% |
| 2009 Q4 | 839.85 Million JPY | -39.55% |
| 2009 FY | 4.67 Billion JPY | 23.66% |
| 2008 FY | 3.77 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 70.996% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 99.517% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 97.666% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 93.595% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -238.752% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 80.715% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | 56.394% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 97.625% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -139.625% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 80.766% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 72.644% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -9.556% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -53.754% |
| Tsumura & Co. | 48.8 Billion JPY | 74.064% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | 62.018% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | 35.215% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 80.142% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | 68.721% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 72.118% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -204.474% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -112.902% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -142.347% |
| MedRx Co., Ltd | 959 Million JPY | -1219.812% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -340.438% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -757.52% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -433.901% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | 47.623% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | 64.279% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -1621.617% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 87.32% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -460.717% |